Insider Trading: StemCells Inc (STEM.O)
STEM.O on Consolidated Issue listed on NASDAQ Capital Market
1.69USD
19 Jun 2013
1.69USD
19 Jun 2013
Price Change (% chg)
$-0.08 (-4.51%)
$-0.08 (-4.51%)
Prev Close
$1.77
$1.77
Open
$1.75
$1.75
Day's High
$1.79
$1.79
Day's Low
$1.68
$1.68
Volume
578,925
578,925
Avg. Vol
315,896
315,896
52-wk High
$2.67
$2.67
52-wk Low
$0.62
$0.62
| BJERKHOLT ERIC H | Options Exercised: 0 | ||
| Trade Date: | Wednesday, 29 Feb 2012 | Price: | 0.00 |
| Title: | Director | Shares Held: | 3,000 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 1,000 |
Institutional Holders
| % Shares Owned: | 6.86% |
| # of Holders: | 40 |
| Total Shares Held: | 2,672,304 |
| 3 Mo. Net Change: | 247,871 |
| # New Positions: | 10 |
| # Closed Positions: | 3 |
| # Increased Positions: | 22 |
| # Reduced Positions: | 7 |
| # Net Buyers: | 15 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
John Schwartz |
77 | 1998 | Independent Chairman of the Board |
Martin McGlynn |
65 | 2001 | President, Chief Executive Officer, Director |
Rodney Young |
49 | 2006 | Chief Financial Officer, Vice President - Finance and Administration |
Eliseo Salinas |
2013 | Executive Vice President, Head - Research and Development | |
Ann Tsukamoto |
2013 | Executive Vice President - Scientific and Strategic Alliances | |
Stewart Craig |
50 | 2008 | Senior Vice President - Development and Operations |
Kenneth Stratton |
43 | 2007 | General Counsel |
Irving Weissman |
72 | 1997 | Director |
Eric Bjerkholt |
53 | 2004 | Independent Director |
R. Scott Greer |
53 | 2010 | Independent Director |
Ricardo Levy |
67 | 2001 | Independent Director |

